M 4 E Common Technical Document for the …
© emea 2006 3 common technical document for the registration of pharmaceuticals for human use: efficacy clinical overview and clinical summary of module 2
Download M 4 E Common Technical Document for the …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Guidelines for good clinical practice (GCP) for trials …
apps.who.intINTRODUCTION Glossary 1. PROVISIONS AND PREREQUISITES FOR A CLINICAL TRIAL 1.1 Justification for the trial 1.2 Ethical principles 1.3 Supporting data for the investigational product
4 Types of Assessments - BreitLinks
breitlinks.com2007 MnCareers Facilitator Guide Page 3 Before students or clients can determine what they like to do in their career, they need to discover who they are. Assessments teach people to learn about themselves.
Tentative Preliminary Scientific Program - …
hplc2018.orgHPLC 2018 Preliminary Scientific Program, page 2 Sunday, July 29, 2018 Great Training Opportunities at HPLC 2018 Optional Short Course Offerings - …
Principles of Lean Software Development - …
ptgmedia.pearsoncmg.comPraise for Implementing Lean Software Development “This book offers a wealth of advice for any organization that wishes to succeed at the software development game. It will help you to realize the value of adopting a product
Filters Fluorescence and Life Science Instrumentation
www.horiba.comFor current product listings, specifications, and pricing: www.glenspectra.co.uk • info@glenspectra.co.uk • +44 020 8204 9517 . Omega Optical celebrates 40 years!
Advances and Emerging Trends in Separations …
www.hplc2018.orgHPLC 2018 Preliminary Scientific Program, page 2 Sunday, July 29, 2018 Great Training Opportunities at HPLC 2018 Optional Short Course Offerings - …
Final Concept Paper Q12: Technical and Regulatory ...
www.ich.orgFINAL Q12 Concept Paper Endorsed: 9 September 2014 -3- product lifecycle management. To date, the main emphasis has been on the implementation of
OECD Recommendation on the Governance of …
www.oecd.orgC – New product B – Modified use A – Usual care Medicinal product Based on Marketing Authorisation (MA) status, with modulating factors: (up/downgrade) - Novelty (new chemical entity/class)